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Abstract
Background: Tanshinone IIA (Tan IIA) is a major active ingredient extracted from Salvia miltiorrhiza,
which has been proved to inhibit metastasis of various cancers including colorectal cancer (CRC).
However, the detailed mechanisms of Tan IIA against CRC metastasis are not well explored. Epithelial-tomesenchymal transition (EMT) exerts an important regulatory role in CRC metastasis, and our previous
mechanism studies demonstrated that β-arrestin1 could regulate CRC EMT partly through β-catenin
signaling pathway. Therefore, in this work we investigated whether Tan IIA could regulate CRC EMT
through β-arrestin1-mediated β-catenin signaling pathway in vivo and in vitro.
Methods: The nude mice tail vein metastasis model was established to observe the effect of Tan IIA on
CRC lung metastasis in vivo. The lung metastasis was evaluated by living animal imaging and
hemaoxylin-eosin staining. The migratory ability of CRC cells in vitro were measured by transwell and
wound healing assays. The protein expression and cellular localization of β-arrestin1 and β-catenin were
characterized by immunofluorescence staining and western blot. The β-catenin signaling pathway related
proteins and EMT associated proteins in CRC cells were detected by western blot and
immunohistochemistry.
Results: Our results showed that Tan IIA inhibited the lung metastases of CRC cells in vivo and extended
the survival time of nude mice. In vitro, Tan IIA increased the expression of E-cadherin, decreased the
secretion of Snail, N-cadherin and Vimentin, thus suppressed EMT and the migratory ability of CRC cells.
Further study found the mechanism involving in Tan IIA regulating EMT and metastasis, referring to the
suppression of β-arrestin1 expression, reduction of β-catenin nuclear localization, thereby the decreased
activity of β-catenin signaling.
Conclusion: Our data revealed a new mechanism of Tan IIA on the suppression of EMT and metastasis in
CRC via β-arrestin1-mediated β-catenin signaling pathway, and provided support for Tan IIA as antimetastatic agents in CRC.

Background
Colorectal cancer (CRC) is the third most common cancer and the second cause of cancer-associated
death in the world, consisting of over 1.7 million new cases and 861,663 deaths per year [1]. High
mortality rate is due to that half of the CRC patients are diagnosed at advanced stages or recurrence and
metastasis after tumor resection [2]. Hence, exploring the molecular mechanism of CRC metastasis,
preventing recurrence and metastasis of CRC, and improving the survival rate of CRC patients have
become the urgent problem to be solved.
Epithelial-to-mesenchymal transition (EMT) plays a key role in CRC metastasis [3]. Generally, epithelial
cells lose cell polarity and the ability of cell adhesion, penetrate the basement membrane and enter the
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circulatory system, then initiate and promote the invasion and metastasis of cancer cells [4]. During EMT,
down-regulation of E-cadherin leads to the loss of cell adhesion, upregulation of Vimentin and N-cadherin
causes the reorganization of the actin cytoskeleton and promotes the motility [5], and upregulation of
transcription factors such as Snail, Slug and Twist induces EMT [6]. In addition, TGF-β/SMADs [7],
PI3K/Akt [8] and other signaling pathways were participated in regulating EMT. In our previous study, we
have found that β-arrestin1 had a higher expression in lung metastases than in primary CRC. Moreover, βarrestin1 could promote EMT and metastasis through repressing the expression of GSK-3β, inhibiting the
degradation of β-catenin, thereby activating β-catenin signaling pathway (Support information for

review).
Tanshinone is an ether or ethanol extract from the root of Salvia miltiorrhiza, and Tan IIA is major active
constituent. Several studies have showed the pharmacological effects of Tan IIA on the apoptosis,
metastasis, drug resistance, and angiogenesis in different cancers [9–11]. However, the mechanisms of
Tan IIA on CRC EMT and metastasis are not well elucidated. In this study, we aim to explore the effect
and mechanism of Tan IIA on CRC EMT and metastasis in vivo and in vitro, and provide a theoretical
basis for further application of Tanshinone IIA in CRC therapy.

Materials And Methods

Cell culture and reagents
Human colorectal cancer cell line HCT-116 (ATCC, USA) was cultured in 1640 medium and LoVo (ATCC,
USA) was cultured in F-12K medium, at 37°C in a 5% CO2 incubator, containing 10% fetal bovine serum
(FBS), 100U/mL penicillin, 100mg/mL streptomycin. Rabbit monoclonal antibodies against human Ecadherin, N-cadherin, Vimentin, Snail, β-arrestin1, GSK-3β, β-catenin, c-Myc and CyclinD1 were purchased
from Cell Signaling Technology (USA). Rabbit monoclonal antibodies against human MMP2 and MMP9
were purchased from Santa Cruz Biotechnology (USA). Mouse monoclonal antibodies against human
GAPDH were purchased from Proteintech (China). Tanshinone IIA was purchased from Selleck (Houston,
TX, USA).

Cell viability assays
Cell Counting Kit-8 (CCK-8) was used to detect cell proliferation. Firstly, the 96-well plate was covered with
1×104 cells/well. Secondly, when the cell density reached 60%, different concentrations of Tan IIA were
added into the plate and incubated for 24 h, 48 h and 72 h. Thirdly, the medium containing CCK-8 reagent
was used to culture the treated cells for 4 hours. Then, absorption was measured at 450 nm with a
microplate reader (Biorad, USA). All experiments were carried out in 6 wells, and each experiment was
repeated at least three times.
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Western blot
In brief, all of the cells were lysed with RIPA Lysis, and the extracted protein was quantified by BCA protein
assay (Beyotime Biotechnology, Shanghai, China). Approximately 50μg of proteins were added into the
10% SDS-PAGE gels for electrophoresis and then transferred onto a polyvinylidene diflfluoride (PVDF)
membrane on ice. After that, PVDF was blocked with 5% BSA, and incubated with the primary antibodies
following by the HRP-conjugated secondary antibodies. The results were examined with enhanced
chemiluminescence (ECL, Millipore, CA, USA), and the target bands analysis by using the Scion Imaging
application (Scion Corporation).

Immunofluorescence microscopy
HCT-116 and LoVo cells were fixed for 30 minutes with 4% paraformaldehyde at room temperature,
permeabilized with Triton X-100 (0.5%) for 15 min, then blocked with 5% BSA solution for 1 h. The cells
were incubated with primary antibodies for 1 h, following by incubating with secondary antibodies at
room temperature for 1 h. After incubation, nuclear was labeled with DAPI for 5 minutes. Finally, cells
were tested with a DMI3000B inverted microscope (Leica, Germany). Transwell assay for migration
HCT-116 and LoVo cells were inoculated into the upper chamber of transwell plate and cultured in 600 μl
1640 or F12K medium with 10 μg/ml fibronectin, medium containing 15% FBS was added in the lower
chamber of transwell plate. Then different concentrations of Tan IIA were added into the upper chamber
and incubated for 48 h. Migrated cells were detected by crystal violet staining, and observed by using
DMI3000B inverted microscope (Leica, Germany). Five random views were selected to count the migrated
cells.

Wound-healing assay
HCT-116 or LoVo cells were seed into 6-well plates for 24 h, then were created an artificial scratch wound
using a 20μl pipette tip and detached cells were removed by washing with PBS three times. After 48 h
incubation, cell migration was photographed using inverted microscope and evaluated by measuring the
difference in wound width.

Animal model
Male BALB/c nude mice (5 weeks old) were purchased from Department of Experimental Animals of
Shanghai University of Traditional Chinese Medicine (Shanghai, China, license No. SCXK 2018-0006) and
fed in specific pathogen-free conditions for 1 week. The mice were injected with 2×106 HCT-116/Luc cells
by the tail vein. Two weeks later, the mice were randomly divided into five groups, 8 in each group. The
mice were treated with different concentrations of Tan IIA (0.5, 1, 2 mg/kg) for 4 weeks by tail vein
injection. For bioluminescence imaging, mice were anesthetized with 1% pentobarbital sodium
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(200μl/per) by intraperitoneal injection, and injected intraperitoneally with D-luciferin (15mg/ml), and
captured the data by using an IVIS Lumina system (Caliper, USA). After that, the lung organs were
excised, fixed in 4% paraformaldehyde, and paraffin-embedded. The lung sections were fully cut, and
paraffin-embedded tissues were cut into 5μm sections. All the lung sections were stained with
hemaoxylin-eosin (HE), and E-cadherin, Vimentin, Snail and β-arrestin1 were detected with
immunohistochemistry (IHC). The animal experiments were performed under the approval of the animal
ethics committee of Shuguang Hospital, Shanghai University of Traditional Chinese Medicine.

Statistical analysis
All the data were presented as the means ± SD of at least three independent experiments and analyzed
with SPSS22.0 Software. The mean values of two groups were compared by Student’s t test. P<0.05 was
considered as statistically significant.

Results

Tan IIA inhibited the lung metastasis of colorectal cancer in
vivo
Tan IIA is a major active ingredient extracted from Salvia miltiorrhiza, which has been proved to inhibit
metastasis of various cancers. In the present study, to assess the effect of Tan IIA on CRC metastasis in

vivo, firstly, the lung metastasis model was established by tail vein injection, and then the mice were
treated with different concentrations of Tan IIA. In vivo imaging results indicated that HCT-116/luc cells
transferred to lung tissue after tail injection, and Tan IIA (0.5, 1, 2 mg/Kg) [9] inhibited the metastatic
ability of HCT-116/luc cells in a concentration-dependent manner (Fig. 1A, 1B). We also found that Tan IIA
could improve the mice, survival. Compared with control group, the life prolongation rates of low, medium
and high dose of Tan IIA in tumor-bearing mice were 8.73%, 19.09% and 34.63%, respectively (Fig. 1C).
After resection of lung metastases, the numbers of lung metastases in Tan IIA groups were significantly
fewer than control group. Especially in the high-dose of Tan IIA group, the number of lung metastases
was the least (Fig. 1D). HE staining was used to observe lung metastases in nude mice, which was
consistent with in vivo imaging results (Fig. 1E).

Tan IIA inhibited the EMT of CRC cells
Above studies have shown that Tan IIA could inhibit lung metastasis of colorectal cancer in vivo, and this
ignites our interesting to explore the potential anti-metastatic mechanism of Tan IIA in vitro. EMT is
mainly featured by the destruction of adherens junctions (AJs), and E-cadherin, N-cadherin, Vimentin and
Snail were the characteristic proteins [12]. Firstly, we detected its anticancer activity of CRC HCT-116 cells
for 24 h, 48 h, 72 h under different concentrations of Tan IIA (0, 1.25, 2.5, 5, 10, 20, 40, 80, 100 μM) by
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using CCK assay. The data showed that Tan IIA inhibited HCT-116 cells (Fig. 2A) in a concentration-and
time-dependent manner. Then, we calculated the IC50 value (17.48 μM for 48 h in HCT-116 cells) of Tan
IIA, and took 0, 5, 10, 20 μM and 48 h as the common dosage and treatment time in the next experiment.
The following data revealed that, treatment with Tan IIA reduced the expression of N-cadherin, Vimentin
and Snail, while E-cadherin had an opposite result in a concentration-dependent manner (Fig. 2B-2E).
Immunofluorescence images demonstrated that, the levels of E-cadherin in the membrane increased, but
the levels of Vimentin in the cytoplasm decreased after adding Tan IIA (Fig. 2F-2I), which was similar to
the results of western blot.

Tan IIA inhibited the migration of CRC cells
Since the effect of Tan IIA on EMT has been confirmed, next we investigated the role of Tan IIA on CRC
metastasis in vitro. Transwell assay showed that, compared with control group, Tan IIA could inhibit the
migration of colorectal cancer cells in a concentration-dependent manner (Fig. 3A-3D). Similar to the
results of Transwell assay, Wound-healing assay suppressed the migratory ability of CRC cells after
treating with Tan IIA 48 h (Fig. 3E-3H). Extracellular matrix (ECM) is the physical barrier in the process of
tumor metastasis. The change of ECM structure is closely related to the invasion and metastasis of
tumor. Abnormal expression of matrix metalloproteinases (MMPs) accounts for degradation of ECM,
especially for MMP-2 and MMP-9 [13-14]. The results indicated that, the expression levels of MMP-2 and
MMP-9 were obviously decreased (Fig. 3I-3L), which was consistent with previous analysis.

Tan IIA inhibited the migration of CRC cells via β-arrestin1mediated β-catenin signaling pathway
To study whether the anti-metastasis effect of Tan IIA was associated with β-arrestin1/β-catenin
signaling pathway in HCT-116 and LoVo cells, GSK-3β, β-catenin, the downstream genes of β-catenin
signaling including c-Myc and CyclinD1 were detected by western blot. As shown in the following figure,
the level of β-arrestin1 was reduced, while the level of GSK-3β was increased when treatment with Tan IIA.
Further studies discovered that Tan IIA inhibited β-catenin translocating into nucleus, and decreased the
accumulation of β-catenin in the nucleus, with a corresponding reduction in c-Myc and CyclinD1 (Fig. 4A4D).

Tan IIA inhibited CRC metastasis via β-arrestin1/β-catenin
signaling pathway in vivo
Next, we investigated metastasis-related proteins in each group of lung metastases by using
immunohistochemistry and western blot. Immunohistochemistry discovered that Tan IIA obviously
decreased β-arrestin1, Vimentin and Snail protein levels, while increased E-cadherin protein level in a
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concentration-dependent manner (Fig. 5A). Consistent with the previous results, lung metastases treated
with Tan IIA had a higher expression of E-cadherin and lower expression of N-cadherin, Vimentin and
Snail (Fig. 5B-5C). Further detection of metastasis-related proteins found that the levels of MMP-2 and
MMP-9 were reduced after Tan IIA treatment (Fig. 5D-5E). The Wnt/β-catenin signaling activity was partly
blocked by Tan IIA. The result was shown that Tan IIA down-regulated the expression levels of β-arrestin1,
β-catenin and the downstream gene of β-catenin, such as c-Myc and CyclinD1, while up-regulated the
protein expression of GSK-3β in a concentration-dependent manner (Fig. 5F-5G)

Discussion
Tan IIA, which is derived from Salvia miltiorrhiza, has been proved to have antioxidant, coronary artery
dilatation and anti-inflammatory effects [15–16]. Recent studies have shown that Tan IIA has anti-cancer
effect in many malignant tumors, such as colon cancer, breast cancer, ovarian cancer [17–19]. Our
previous studies demonstrated that Tan IIA had an effect on the invasion and metastasis of CRC [9]. EMT
is characterized by loss of polarity of epithelial cells and acquisition of mesenchymal properties, which is
closely related to invasion and distant metastasis of tumor cells [20]. When EMT was triggered, the
epithelial marker E-cadherin and mesenchymal marks Vimentin had significant changes [21]. In vivo, our
present results suggested that Tan IIA could inhibit lung metastasis of CRC and improve the survival of
tumor-bearing mice via suppressing the EMT process. In vitro, the data indicated that Tan IIA upregulated
E-cadherin levels and downregulated Vimentin levels through inhibiting the expression of Snail
transcription factors in a concentration-dependent manner. As EMT is one of the most key steps for
metastasis of CRC, and likewise, we found the expression of MMP-2 and MMP-9 were decreased after
treating with Tan IIA.
A series of studies have found that Wnt/β-catenin acts as a major way to be involved in EMT and
invasion and metastasis of tumors [22–24]. When canonical Wnt signaling pathway is abnormally
activated, the function of Axin, APC, GSK-3β and CK1α complex is greatly restricted, accumulated βcatenin enters into the nucleus from cytoplasm, then the β-catenin/TCF/LEF complex transcriptional
activates Snail directly and triggers the EMT [25–26]. Our previous data discovered that, β-arrestin1
promoted EMT through β-catenin signaling pathway in CRC progression in vivo and in vitro. The
mechanism of β-arrestin1 regulating EMT and metastasis partly through decreasing the expression of
GSK-3β, leading to the accumulation of β-catenin in the cytoplasm and promoting β-catenin to get into
the nucleus. In present study, firstly, in vitro experimental results demonstrated that Tan IIA inhibited the
expression of β-arrestin1 while promoted the expression of GSK-3β, thus blocking β-catenin entry into the
nucleus. Subsequently, the expression of c-Myc and CyclinD1 were reduced as a result of the inhibition of
β-catenin. Secondly, in vivo experiments obtained a similar result of Tan IIA, demonstrated the effects of
Tan IIA on EMT, β-catenin signaling pathway and its related proteins.

Conclusion
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In summary, our results found that Tan IIA could inhibit EMT and metastasis in CRC through β-arrestin1mediated β-catenin signaling pathway, which partly accounting for its potential anti-metastatic
mechanism for CRC (Fig. 6).
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Figures

Figure 1
Tan IIA inhibited the metastasis of colorectal cancer in vivo. A-B Each group of mice were injected with
HCT-116/luc cells by the tail vein. After treatment with Tan IIA drug concentration (0.5, 1, 2 mg/Kg) for 4
weeks, Luciferase imaging data was collected by IVIS Lumina system. ***P＜0.001, compared with control
group. C The survival of tumor-bearing mice were evaluated, *P＜0.05; **P＜0.01; ***P＜0.001, compared
with control group. D-E The lung metastasis were excised, hemaoxylin-eosin (H&E) staining of tumor
cytostructure and cytomorphology analysis in tumors, and the numbers of metastatic lesions were
counted, *P＜0.05; ***P＜0.001, compared with control group.
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Figure 2
Tan IIA inhibited EMT in colorectal cancer cells. A CCK-8 assay was used to detect the cellular inhibition
of Tan IIA (0, 1.25, 2.5, 5, 10, 20, 40, 80, 100 μM) in HCT116 cells for 24, 48, and 72 h. B-E HCT-116 cells
and LoVo cells were treated with Tan IIA at 0 μM, 5 μM, 10 μM, and 20 μM, western blot was used to
detect the expression of E-cadherin, N-cadherin, Snail, Vimentin, *P＜0.05; **P＜0.01; ***P＜0.001, compared
with group without treatment of Tan IIA. F-I The effect of Tan IIA on pithelial phenotype marker E-cadherin
and mesenchymal phenotype marker Vimentin were detected by immunofluorescence staining.

Page 13/17

Figure 3
Tan IIA inhibited the migration of CRC cells. A-D HCT-116 and LoVo cells treated with different
concentration of Tan IIA, transwell assay was used to detect the migratory cells and count from five
random microscopic fields, *P＜0.05; **P＜0.01, **P＜0.01, compared with group without treatment of Tan
IIA. E-H HCT-116 and LoVo cells treated with or without Tan IIA for 48 h, collection of the wound-healing
assay data are shown. The black line was used to mark the ranges of the scratches, *P＜0.05; **P＜0.01,
**P＜0.01, compared with group without treatment of Tan IIA. I-L The expression of MMP-2 and MMP-9
were examined by western blot, *P＜0.05; **P＜0.01, **P＜0.01, compared with group without treatment of
Tan IIA.
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Figure 4
Tan IIA inhibited β-arrestin1-mediated β-catenin signaling pathway. A-B Western blot analysis the
expression of β-arrestin1, GSK-3β, β-catenin, c-Myc, CyclinD1 in HCT-116 cells with or without Tan IIA
treatment, *P＜0.05; **P＜0.01; ***P＜0.001, compared with group with Tan IIA at 0 μM. C-D After using Tan
IIA at 0 μM, 5 μM, 10 μM, 20 μM treatment in LoVo cells, the level of β-arrestin1, GSK-3β, β-catenin, and
downstream genes including c-Myc, CyclinD1 were detected by western blot, *P＜0.05; **P＜0.01; ***P＜
0.001, compared with group without treatment of Tan IIA.
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Figure 5
Tan IIA inhibited metastasis of CRC via β-arrestin1/β-catenin signaling pathway in vivo. A
Immunohistochemistry detected the expression of β-arrestin1, E-cadherin, Vimentin and Snail in each
groups. B-C Western blot was applied to assess the expression of E-cadherin, N-cadherin, Snail and
Vimentin, *P＜0.05; **P＜0.01; ***P＜0.001, compared with control group. D-E The levels of MMP-2 and
MMP-9 were checked, **P＜0.01, compared with control group. F-G The protein expression of β-arrestin1,
GSK-3β, β-catenin, c-Myc and CyclinD1 were examined by western blot, *P＜0.05; **P＜0.01, ***P＜0.001,
compared with control group.
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Figure 6
Hypothetical diagram of the mechanism of Tanshinone IIA on EMT and metastasis in colorectal cancer.
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